BioSig Technologies (BSGM) Completes Merger, Shifts Focus to Asset Tokenization | BSGM Stock News

Author's Avatar
May 28, 2025
Article's Main Image

BioSig Technologies (BSGM, Financial) and Streamex Exchange have completed their planned share exchange transaction, forging a new entity dedicated to the tokenization of real-world assets. This strategic move primarily aims to bring commodities onto blockchain platforms. The newly formed company will be spearheaded by Henry McPhie, who is stepping in as Chief Executive Officer and will also be part of the Board of Directors. McPhie previously co-founded Streamex.

Morgan Lekstrom, another co-founder from Streamex, will assume the position of Chairman of the Board. In a significant transition, the current BioSig CEO, Anthony Amato, will relinquish his CEO duties while remaining engaged with the company as a board member. This reorganization is expected to facilitate the company's growth and technological scaling, enhancing its position in the burgeoning sectors of tokenization and commodities. The merger represents a pivotal advancement for both companies, with ambitious plans to expand market influence and technological capabilities.

Wall Street Analysts Forecast

1927781161434771456.png

Based on the one-year price targets offered by 1 analysts, the average target price for BioSig Technologies Inc (BSGM, Financial) is $2.50 with a high estimate of $2.50 and a low estimate of $2.50. The average target implies an downside of 55.67% from the current price of $5.64. More detailed estimate data can be found on the BioSig Technologies Inc (BSGM) Forecast page.

Based on the consensus recommendation from 1 brokerage firms, BioSig Technologies Inc's (BSGM, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for BioSig Technologies Inc (BSGM, Financial) in one year is $0.30, suggesting a downside of 94.68% from the current price of $5.64. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the BioSig Technologies Inc (BSGM) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.